Table 3. Basal predictors of change over time in serum PTH (ΔPTH) by general linear mixed model.
Beta (C.I. 95%) | P | |
---|---|---|
Time (months) | 0.06 (-0.38; 0.24) | 0.673 |
Age (years) | 0.12 (-0.24; 0.48) | 0.517 |
Male gender (yes vs no) | 4.87 (-5.0; 14.75) | 0.333 |
Diabetes (yes vs no) | 7.40 (-3.19; 17.98) | 0.171 |
CKD stage 1–2 | Ref | |
Stage 3a | 3.93 (-11.87;19.73) | 0.626 |
Stage 3b | 15.35 (0.64; 30.06) | 0.041 |
Stage 4 | 35.14 (19.78–50.49) | <0.0001 |
Stage 5 | 58.95 (38.12–79.79) | <0.0001 |
Hypertension (yes vs no) | 1.64 (-18.7; 22.0) | 0.874 |
Prior CVD (yes vs no)) | 7.28 (-4.49; 19.05) | 0.225 |
Serum Phosphate (mg/dL) | 10.09 (2.78;17.40) | 0.007 |
Serum total Calcium (mg/dL) | -6.35(-14.89; 2.19) | 0.145 |
Serum PTH (pg/mL) | -0.38 (-0.43;-0.33) | <0.0001 |
Proteinuria (mg/day) | 1.44 (-2.98; 5.85) | 0.523 |
Constant | 34.5 (-52.87; 121.91) | 0.439 |